Daily FNArena News

Morgan Stanley has downgraded outperformer Ramsay Health Care to an Underweight rating.

The Chartist believes more weakness is necessary for the ASX200 before a major low will be in place.

FNArena shares Your Editor’s response to a subscriber question about Qantas, Billabong, Tatts and NIB Holdings.

Weekly update on recommendation, target price, and earnings forecast changes.

Resource Investor’s interview with rare earth expert Jack Lifton reveals some interesting potential for Australian rare earth producers.

Forex.com’s Chris Tedder believes uncertainty has now become Asia’s biggest problem.

Robert Clayton of GTL Management reports a significant technical level is looming to the downside for the ASX200.

Billabong has been forced into a highly dilutive capital raising and lowered earnings guidance at the same time, leading brokers to suggest the share price will remain under pressure.

Ahead of the Herd’s Rick Mills reveals some alarming truths about the average American’s understanding of interest rates and stock markets. How do you fair?

Peter Switzer of the Switzer Super Report visits Fountain Lakes to suggest that while all looks bad, it may soon look a lot better.